ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,464.62
      -0.16%
      US Tech 100
      19,220.00
      -0.20%
      Dow Jones
      39,150.33
      0.04%
      Brent Oil
      84.39
      0.00%
      Bitcoin
      64,034.46
      -0.33%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Greenwich LifeSciences Inc (GLSI)

      7. Greenwich LifeSciences Inc (GLSI) Financials

      Greenwich LifeSciences Inc

      Greenwich LifeSciences Inc (GLSI)

      NASDAQ
      16.27
      0.97
      (6.34%)
      Closed June 23 4:00PM
      Delayed by 15 minutes
      16.24
      -0.03
      (-0.18%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Greenwich LifeSciences Inc Financial Summary

      The current GLSI market cap is 209.56M. The company's latest EPS is USD -0.6904 and P/E is -23.52.

      Income Statement

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -2.89M-2.24M-1.75M-2.5M-2.84M
      Net Income -2.79M-2.13M-1.63M-2.39M-2.75M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0000
      Operating Income -1.86M-4.6M-8.04M-9.33M
      Net Income -1.86M-4.57M-7.83M-8.89M

      Balance Sheet

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 13.48M11.92M10.95M9.15M7M
      Total Liabilities 263k235k301k297k295k
      Total Equity 13.21M11.68M10.65M8.85M6.7M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 28.68M27.22M13.48M7M
      Total Liabilities 1.05M385k263k295k
      Total Equity 27.63M26.83M13.21M6.7M

      Cash Flow

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)USD ($)USD ($)
      Operating -6.2M-1.56M-2.52M-4.32M-6.48M
      Investing N/A N/A N/A N/A N/A
      Financing -7.54M N/A N/A N/A N/A
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Operating -1.15M-4.29M-6.2M-6.48M
      Investing N/A N/A N/A N/A
      Financing 29.81M2.84M-7.54M N/A

      Stats and Ratios

      Market Cap 209.56M
      Price to Earnings Ratio -23.52
      Price to Sales Ratio 0
      Price to Cash Ratio 29.93
      Price to Book Ratio 31.22
      Dividend Yield -

      Share Statistics

      Shares Outstanding 12.88M
      Average Volume (1 week) 69.74k
      Average Volume (1 Month) 33.96k
      52 Week Change 51.77%
      52 Week High 21.44
      52 Week Low 7.58
      Spread (Intraday) 4.23 (20.89%)

      Company Info

      Company Name Greenwich LifeSciences Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.greenwichlifesciences.com
      Industry pharmaceutical preparations (2834)